- Home
- GORO vs UNCY Comparison
GORO vs UNCY Comparison
Compare GORO & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORO
- UNCY
- Stock Information
- Founded
- GORO 1998
- UNCY 2016
- Country
- GORO United States
- UNCY United States
- Employees
- GORO N/A
- UNCY N/A
- Industry
- GORO Precious Metals
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- GORO Basic Materials
- UNCY Health Care
- Exchange
- GORO Nasdaq
- UNCY Nasdaq
- Market Cap
- GORO 63.9M
- UNCY 74.2M
- IPO Year
- GORO N/A
- UNCY 2021
- Fundamental
- Price
- GORO $0.75
- UNCY $4.36
- Analyst Decision
- GORO Strong Buy
- UNCY Strong Buy
- Analyst Count
- GORO 2
- UNCY 4
- Target Price
- GORO $1.38
- UNCY $63.75
- AVG Volume (30 Days)
- GORO 2.2M
- UNCY 483.3K
- Earning Date
- GORO 11-04-2025
- UNCY 08-14-2025
- Dividend Yield
- GORO N/A
- UNCY N/A
- EPS Growth
- GORO N/A
- UNCY N/A
- EPS
- GORO N/A
- UNCY N/A
- Revenue
- GORO $49,824,000.00
- UNCY N/A
- Revenue This Year
- GORO N/A
- UNCY N/A
- Revenue Next Year
- GORO $117.97
- UNCY $3,131.28
- P/E Ratio
- GORO N/A
- UNCY N/A
- Revenue Growth
- GORO N/A
- UNCY N/A
- 52 Week Low
- GORO $0.12
- UNCY $3.24
- 52 Week High
- GORO $0.82
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- GORO 80.31
- UNCY 49.39
- Support Level
- GORO $0.45
- UNCY $4.15
- Resistance Level
- GORO $0.48
- UNCY $4.35
- Average True Range (ATR)
- GORO 0.04
- UNCY 0.24
- MACD
- GORO 0.03
- UNCY 0.05
- Stochastic Oscillator
- GORO 94.85
- UNCY 53.76
About GORO Gold Resource Corporation
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.